- AUD/USD dipped under 0.7250 in recent trade as downside in equities/Australia Omicron concerns hurts the Aussie.
- Short-term economic pain as a result of Omicron may be enough to discourage the RBA from axing QE in February.
A broadly risk-off market tone that has seen global equity markets turn lower for a second day on Thursday seems to be taking its toll on the Aussie, as well as potentially some domestic Australian pandemic woes. The underperforming AUD has now dropped more than 0.6% on the day versus the US dollar, with AUD/USD recently dipped below 0.7250, as traders mull the economic impact of surging Omicron infections and whether it will have any bearing on upcoming RBA policy decisions.
This week’s Australia November Retail Sales report showed a much stronger than expected rebound as the Australian economy continued to open up from its Q3 lockdowns, solidifying expectations that, prior to the rapid spread of Omicron, Australia’s economy had been growing strongly. However, after reaching record-high levels in December, Westpac said on Friday that card spending in the country had fallen sharply in the first two weeks of January. The RBA views Omicron as unlikely to derail Australia’s economic recovery, but recent weakness might encourage them not to abruptly axe their QE buying in February and rather instead opt to taper and continue purchases to May.
The above expectations that the current economic weakness may translate into a more dovish RBA outcome may well be one of the factors weighing on AUD on Friday alongside the generally more risk-off tone. In terms of the dollar side of the AUD/USD equation, the pair saw very little reaction to the latest (weaker than expected) US Retail Sales report and (weaker than expected) Industrial Production numbers. Broadly speaking, the US dollar remains on a fragile footing despite this week's hawkishness from FOMC members and hot consumer and producer inflation metrics. That suggests upcoming University of Michigan Consumer Sentiment survey data (the preliminary January release) is unlikely to generate much by way of FX market volatility, but will be worth watching nonetheless.
|Today last price||0.7242|
|Today Daily Change||-0.0035|
|Today Daily Change %||-0.48|
|Today daily open||0.7277|
|Previous Daily High||0.7315|
|Previous Daily Low||0.7272|
|Previous Weekly High||0.7278|
|Previous Weekly Low||0.713|
|Previous Monthly High||0.7278|
|Previous Monthly Low||0.6993|
|Daily Fibonacci 38.2%||0.7289|
|Daily Fibonacci 61.8%||0.7299|
|Daily Pivot Point S1||0.7261|
|Daily Pivot Point S2||0.7246|
|Daily Pivot Point S3||0.7219|
|Daily Pivot Point R1||0.7304|
|Daily Pivot Point R2||0.7331|
|Daily Pivot Point R3||0.7346|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.